Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance

Understanding the mechanisms of cancer therapeutic resistance is fundamental to improving cancer care. There is clear benefit from chemotherapy in different breast cancer settings; however, knowledge of the mutations and genes that mediate resistance is incomplete. In this study, by modeling chemore...

ver descrição completa

Detalhes bibliográficos
Principais autores: Ruiz de Garibay, Gorka, Mateo, Francesca, Stradella, Agostina, Valdés-Mas, Rafael, Palomero, Luis, Serra-Musach, Jordi, Puente, Diana A., Díaz-Navarro, Ander, Vargas-Parra, Gardenia, Tornero, Eva, Morilla, Idoia, Farré, Lourdes, Martinez-Iniesta, María, Herranz, Carmen, McCormack, Emmet, Vidal, August, Petit, Anna, Soler, Teresa, Lázaro, Conxi, Puente, Xose S., Villanueva, Alberto, Pujana, Miguel Angel
Formato: Online Atigo Texto
Idioma:English
Publicado em: The Company of Biologists Ltd 2018
Assuntos:
Research Article
Acesso em linha:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992609/
https://www.ncbi.nlm.nih.gov/pubmed/29666142
http://dx.doi.org/10.1242/dmm.032292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992609/
https://www.ncbi.nlm.nih.gov/pubmed/29666142
http://dx.doi.org/10.1242/dmm.032292

Registros relacionados